Brief: Imagion Biosystems Says MoU To Develop Early Pancreatic Cancer Diagnosis Platform
11/08/2023 02:28
Aug 11 (Reuters) - Imagion Biosystems Ltd IBX.AX :
* MOU TO DEVELOP EARLY PANCREATIC CANCER DIAGNOSIS PLATFORM
* PRESTIGE BIOPHARMA AND IMAGION BIOSYSTEMS SIGN AN MOU
Source text for Eikon: ID:nASX4thmcD
Further company coverage: IBX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imagion Biosystems
See all newsBrief: Imagion Biosystems Resumes Magsense Nanoparticle Manufacturing Capabilities
Brief: Imagion Biosystems Secures AU$3.75M In Capital Raise Following FDA Clearance Of Phase 2 Clinical Trial
Brief: Imagion Biosystems Secures A$3.75 Million In Firm Commitments Under Capital Raising
Australia's Imagion Biosystems falls on discounted placement
Brief: Imagion Biosystems Seeks Trading Halt